Molecular Cell · 2012 · 170 citations · 58 references
Life SciencesCancer BiologyMolecular BiologyCancer GeneticsDna RepairMolecular OncologyDna DamageDna Damage RecognitionDna Double-strand Break RepairDna Strand BreaksDouble-strand Break RepairHomologous RecombinationDna Damage Checkpoint KinasesDna Damage Checkpoint SignalingDna Damage Response SignalingDna Damage ResponsesNijmegen Breakage SyndromeRad51 ProteinRad51 RecombinaseRecombinase Regulation
Homologous recombination repairs DNA breaks during S and G2 phases, yet its regulatory mechanisms remain poorly understood. The study investigates how Polo-like kinase 1 phosphorylates Rad51 at serine 14 during the cell cycle and DNA damage. Plk1-mediated S14 phosphorylation permits CK2 to phosphorylate Rad51 at threonine 13, enabling direct binding to Nbs1. This phosphorylation cascade promotes Rad51 recruitment to damage sites, enhances resistance to genotoxic stress, and links Plk1 activity to HR repair and cancer development.
Homologous recombination (HR) plays an important role in the maintenance of genome integrity. HR repairs broken DNA during S and G2 phases of the cell cycle but its regulatory mechanisms remain elusive. Here, we report that Polo-like kinase 1 (Plk1), which is vital for cell proliferation and is frequently upregulated in cancer cells, phosphorylates the essential Rad51 recombinase at serine 14 (S14) during the cell cycle and in response to DNA damage. Strikingly, S14 phosphorylation licenses subsequent Rad51 phosphorylation at threonine 13 (T13) by casein kinase 2 (CK2), which in turn triggers direct binding to the Nijmegen breakage syndrome gene product, Nbs1. This mechanism facilitates Rad51 recruitment to damage sites, thus enhancing cellular resistance to genotoxic stresses. Our results uncover a role of Plk1 in linking DNA damage recognition with HR repair and suggest a molecular mechanism for cancer development associated with elevated activity of Plk1.
58
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Helen E. Bryant, Niklas Schultz, Huw D. Thomas et al. · Nature · 2005 · 5.2K citations
Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome
Raymonda Varon, Christine Vissinga, Matthias Platzer et al. · Cell · 1998 · 1.1K citations · Full text